Wegovy 1.7

Wegovy (semaglutide) is an FDA-approved weight loss medication designed to help adults manage obesity and weight-related conditions. The 1.7 mg dose serves as a crucial transition step toward the full maintenance dose, enhancing appetite control and calorie regulation for sustained weight loss success.

This dose is ideal for individuals advancing from lower doses (0.25 mg, 0.5 mg, and 1.0 mg) as part of the prescribed dose-escalation plan to achieve maximum efficacy.

Who Can Use Wegovy?

Wegovy is recommended for:

• Adults with obesity: BMI of 30 or higher.
• Adults with overweight: BMI of 27 or higher with at least one weight-related condition, such as:
  • Type 2 diabetes
  • High blood pressure
  • Sleep apnea

Before starting Wegovy, consult your healthcare provider to ensure it aligns with your health and weight loss goals.

How Does Wegovy Work?

The active ingredient, semaglutide, is a GLP-1 receptor agonist that:

• Mimics natural hormones that regulate appetite, reducing hunger and curbing cravings.
• Slows stomach emptying, leading to reduced calorie intake.
• Enhances weight loss when combined with a reduced-calorie diet and increased physical activity.

The 1.7 mg dose prepares your body for the maintenance dose of 2.4 mg while continuing to deliver measurable results.

How to Use Wegovy

• Administration: Inject once weekly using the pre-filled pen.
• Injection Sites: Abdomen, thigh, or upper arm. Rotate injection sites to avoid irritation.
• Ease of Use: Self-administered at home with no need for mixing or additional preparation.

Follow your healthcare provider’s advice regarding diet and exercise to maximize results. Full Instructions for Use can be found here.

Warnings and Precautions

Do not use Wegovy if you:

• Are allergic to semaglutide or its ingredients.
• Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Are pregnant, planning to become pregnant, or breastfeeding.

Consult your doctor if you:

• Have pancreatitis or a history of pancreatic inflammation.
• Are managing diabetes, particularly if using insulin or other medications.
• Have experienced low blood sugar (hypoglycemia).
• Have diabetic eye disease (retinopathy).

What’s Included

• 1 Pre-filled injection pen: 1.7 mg semaglutide
• 1 Needle (single-use)

Each pen is disposable and intended for single use only.

Frequently Asked Questions

1. What is the purpose of the 1.7 mg dose?

• The 1.7 mg dose bridges the gap between earlier doses and the full maintenance dose of 2.4 mg, enhancing your body’s adjustment and minimizing side effects.

2. How long should I stay on the 1.7 mg dose?

• Typically, patients remain on the 1.7 mg dose for 4 weeks before transitioning to the 2.4 mg maintenance dose, as directed by their healthcare provider.

3. What should I do if I miss a dose?

• If less than 5 days have passed, take the missed dose as soon as possible. If more than 5 days have passed, skip the missed dose and resume your regular schedule.

4. Can Wegovy® 1.7 mg be used with other medications?

• Inform your doctor of all medications you’re taking, especially diabetes medications, as dose adjustments may be required to avoid low blood sugar.

5. Are side effects common at this stage?

• Side effects like nausea, diarrhea, or abdominal discomfort may occur as your body adjusts but typically subside over time. Consult your doctor if they persist.

6. How should I store Wegovy® pens?

• Refrigerate (2°C to 8°C). If needed, pens can be stored at room temperature (below 30°C) for up to 28 days. Do not freeze.